Global /China /Healthcare /Diagnostics & Research /603127
chevron_leftBack

Joinn Laboratories(China)Co.,Ltd.

603127
SSE: 603127 Delayed
15.59CNY -0.4%
2.14 USD
As of 24 April 2025, Joinn Laboratories(China)Co.,Ltd. has a market cap of $1.48B USD, ranking #6464 globally and #1557 in China. It ranks #609 in the Healthcare sector, and #39 in the Diagnostics & Research industry.
Global Rank
6464
Country Rank
1557
Sector Rank
609
Industry Rank
39
Key Stats
Market Cap
$1.48BUSD
10.8B CNY
Enterprise Value
$1.16BUSD
8.46B CNY
Revenue (TTM)
$276.98MUSD
2.02B CNY
EBITDA (TTM)
$36.21MUSD
263.83M CNY
Net Income (TTM)
$10.17MUSD
74.08M CNY
EBITDA Margin
13%
Profit Margin
3.7%
PE Ratio
155.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Dapeng Gao open_in_new
Employees
2,510
Founded
1995
Website
joinn-lab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.4% 1.1% -26% -0.5% -10% -8%

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
603127
北京昭衍新药研究中心股份有限公司 Class A
ISIN: CNE100002W27
Shares Out.:
614.974M1 Shares Float: 331.335M2
TV:
SA:
YF:
GF:
BA:
MS:
15.59 CNY
Hong Kong Stock Exchange
MIC: XHKG
6127
北京昭衍新药研究中心股份有限公司 Class H
ISIN: CNE100004BP3
Shares Out.:
118.995M1 Shares Float: 105.796M2
TV:
SA:
YF:
GF:
BA:
MS:
10.22 HKD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Joinn Laboratories(China)Co.,Ltd.

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Similar Companies

Industry: Diagnostics & Research (China)
Name
Market Cap diff.
WuXi AppTec Co., Ltd.
603259
$22.16B
161.5B CNY
1K%
WuXi XDC Cayman Inc.
2268
$5.69B
44.12B HKD
284%
Hangzhou Tigermed Consulting Co., Ltd.
300347
$4.98B
36.27B CNY
236%
BGI Genomics Co., Ltd.
300676
$2.54B
18.51B CNY
71%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
603882
$1.84B
13.44B CNY
24%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
11K%
Danaher Corp.
DHR
$140.45B
9K%
Lonza Group AG
LONN
$46.75B
38.79B CHF
3K%
IDEXX Laboratories, Inc.
IDXX
$34.63B
2K%
Agilent Technologies, Inc.
A
$29.94B
2K%